Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Edaravone Injection Market Growth 2022-2028

  • LP 4817878
  • 72 Pages
  • February 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Edaravone Injection will have significant change from previous year. According to our (LP Information) latest study, the global Edaravone Injection market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Edaravone Injection market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.

The United States Edaravone Injection market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Edaravone Injection market, reaching US$ million by the year 2028. As for the Europe Edaravone Injection landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Edaravone Injection players cover Mitsubishi Tanabe Pharma, , , and , etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Edaravone Injection market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

20ml

100ml

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Hospital

Pharmacy

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Mitsubishi Tanabe Pharma

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Edaravone Injection Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Edaravone Injection by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Edaravone Injection by Country/Region, 2017, 2022 & 2028

2.2 Edaravone Injection Segment by Type

2.2.1 20ml

2.2.2 100ml

2.3 Edaravone Injection Sales by Type

2.3.1 Global Edaravone Injection Sales Market Share by Type (2017-2022)

2.3.2 Global Edaravone Injection Revenue and Market Share by Type (2017-2022)

2.3.3 Global Edaravone Injection Sale Price by Type (2017-2022)

2.4 Edaravone Injection Segment by Application

2.4.1 Hospital

2.4.2 Pharmacy

2.5 Edaravone Injection Sales by Application

2.5.1 Global Edaravone Injection Sale Market Share by Application (2017-2022)

2.5.2 Global Edaravone Injection Revenue and Market Share by Application (2017-2022)

2.5.3 Global Edaravone Injection Sale Price by Application (2017-2022)

3 Global Edaravone Injection by Company

3.1 Global Edaravone Injection Breakdown Data by Company

3.1.1 Global Edaravone Injection Annual Sales by Company (2020-2022)

3.1.2 Global Edaravone Injection Sales Market Share by Company (2020-2022)

3.2 Global Edaravone Injection Annual Revenue by Company (2020-2022)

3.2.1 Global Edaravone Injection Revenue by Company (2020-2022)

3.2.2 Global Edaravone Injection Revenue Market Share by Company (2020-2022)

3.3 Global Edaravone Injection Sale Price by Company

3.4 Key Manufacturers Edaravone Injection Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Edaravone Injection Product Location Distribution

3.4.2 Players Edaravone Injection Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Edaravone Injection by Geographic Region

4.1 World Historic Edaravone Injection Market Size by Geographic Region (2017-2022)

4.1.1 Global Edaravone Injection Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Edaravone Injection Annual Revenue by Geographic Region

4.2 World Historic Edaravone Injection Market Size by Country/Region (2017-2022)

4.2.1 Global Edaravone Injection Annual Sales by Country/Region (2017-2022)

4.2.2 Global Edaravone Injection Annual Revenue by Country/Region

4.3 Americas Edaravone Injection Sales Growth

4.4 APAC Edaravone Injection Sales Growth

4.5 Europe Edaravone Injection Sales Growth

4.6 Middle East & Africa Edaravone Injection Sales Growth

5 Americas

5.1 Americas Edaravone Injection Sales by Country

5.1.1 Americas Edaravone Injection Sales by Country (2017-2022)

5.1.2 Americas Edaravone Injection Revenue by Country (2017-2022)

5.2 Americas Edaravone Injection Sales by Type

5.3 Americas Edaravone Injection Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Edaravone Injection Sales by Region

6.1.1 APAC Edaravone Injection Sales by Region (2017-2022)

6.1.2 APAC Edaravone Injection Revenue by Region (2017-2022)

6.2 APAC Edaravone Injection Sales by Type

6.3 APAC Edaravone Injection Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Edaravone Injection by Country

7.1.1 Europe Edaravone Injection Sales by Country (2017-2022)

7.1.2 Europe Edaravone Injection Revenue by Country (2017-2022)

7.2 Europe Edaravone Injection Sales by Type

7.3 Europe Edaravone Injection Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Edaravone Injection by Country

8.1.1 Middle East & Africa Edaravone Injection Sales by Country (2017-2022)

8.1.2 Middle East & Africa Edaravone Injection Revenue by Country (2017-2022)

8.2 Middle East & Africa Edaravone Injection Sales by Type

8.3 Middle East & Africa Edaravone Injection Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Edaravone Injection

10.3 Manufacturing Process Analysis of Edaravone Injection

10.4 Industry Chain Structure of Edaravone Injection

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Edaravone Injection Distributors

11.3 Edaravone Injection Customer

12 World Forecast Review for Edaravone Injection by Geographic Region

12.1 Global Edaravone Injection Market Size Forecast by Region

12.1.1 Global Edaravone Injection Forecast by Region (2023-2028)

12.1.2 Global Edaravone Injection Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Edaravone Injection Forecast by Type

12.7 Global Edaravone Injection Forecast by Application

13 Key Players Analysis

13.1 Mitsubishi Tanabe Pharma

13.1.1 Mitsubishi Tanabe Pharma Company Information

13.1.2 Mitsubishi Tanabe Pharma Edaravone Injection Product Offered

13.1.3 Mitsubishi Tanabe Pharma Edaravone Injection Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Mitsubishi Tanabe Pharma Main Business Overview

13.1.5 Mitsubishi Tanabe Pharma Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Edaravone Injection Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Edaravone Injection Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of 20ml

Table 4. Major Players of 100ml

Table 5. Global Edaravone Injection Sales by Type (2017-2022) & (K MT)

Table 6. Global Edaravone Injection Sales Market Share by Type (2017-2022)

Table 7. Global Edaravone Injection Revenue by Type (2017-2022) & ($ million)

Table 8. Global Edaravone Injection Revenue Market Share by Type (2017-2022)

Table 9. Global Edaravone Injection Sale Price by Type (2017-2022) & (USD/MT)

Table 10. Global Edaravone Injection Sales by Application (2017-2022) & (K MT)

Table 11. Global Edaravone Injection Sales Market Share by Application (2017-2022)

Table 12. Global Edaravone Injection Revenue by Application (2017-2022)

Table 13. Global Edaravone Injection Revenue Market Share by Application (2017-2022)

Table 14. Global Edaravone Injection Sale Price by Application (2017-2022) & (USD/MT)

Table 15. Global Edaravone Injection Sales by Company (2020-2022) & (K MT)

Table 16. Global Edaravone Injection Sales Market Share by Company (2020-2022)

Table 17. Global Edaravone Injection Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Edaravone Injection Revenue Market Share by Company (2020-2022)

Table 19. Global Edaravone Injection Sale Price by Company (2020-2022) & (USD/MT)

Table 20. Key Manufacturers Edaravone Injection Producing Area Distribution and Sales Area

Table 21. Players Edaravone Injection Products Offered

Table 22. Edaravone Injection Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Edaravone Injection Sales by Geographic Region (2017-2022) & (K MT)

Table 26. Global Edaravone Injection Sales Market Share Geographic Region (2017-2022)

Table 27. Global Edaravone Injection Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Edaravone Injection Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Edaravone Injection Sales by Country/Region (2017-2022) & (K MT)

Table 30. Global Edaravone Injection Sales Market Share by Country/Region (2017-2022)

Table 31. Global Edaravone Injection Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Edaravone Injection Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Edaravone Injection Sales by Country (2017-2022) & (K MT)

Table 34. Americas Edaravone Injection Sales Market Share by Country (2017-2022)

Table 35. Americas Edaravone Injection Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Edaravone Injection Revenue Market Share by Country (2017-2022)

Table 37. Americas Edaravone Injection Sales by Type (2017-2022) & (K MT)

Table 38. Americas Edaravone Injection Sales Market Share by Type (2017-2022)

Table 39. Americas Edaravone Injection Sales by Application (2017-2022) & (K MT)

Table 40. Americas Edaravone Injection Sales Market Share by Application (2017-2022)

Table 41. APAC Edaravone Injection Sales by Region (2017-2022) & (K MT)

Table 42. APAC Edaravone Injection Sales Market Share by Region (2017-2022)

Table 43. APAC Edaravone Injection Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Edaravone Injection Revenue Market Share by Region (2017-2022)

Table 45. APAC Edaravone Injection Sales by Type (2017-2022) & (K MT)

Table 46. APAC Edaravone Injection Sales Market Share by Type (2017-2022)

Table 47. APAC Edaravone Injection Sales by Application (2017-2022) & (K MT)

Table 48. APAC Edaravone Injection Sales Market Share by Application (2017-2022)

Table 49. Europe Edaravone Injection Sales by Country (2017-2022) & (K MT)

Table 50. Europe Edaravone Injection Sales Market Share by Country (2017-2022)

Table 51. Europe Edaravone Injection Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Edaravone Injection Revenue Market Share by Country (2017-2022)

Table 53. Europe Edaravone Injection Sales by Type (2017-2022) & (K MT)

Table 54. Europe Edaravone Injection Sales Market Share by Type (2017-2022)

Table 55. Europe Edaravone Injection Sales by Application (2017-2022) & (K MT)

Table 56. Europe Edaravone Injection Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Edaravone Injection Sales by Country (2017-2022) & (K MT)

Table 58. Middle East & Africa Edaravone Injection Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Edaravone Injection Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Edaravone Injection Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Edaravone Injection Sales by Type (2017-2022) & (K MT)

Table 62. Middle East & Africa Edaravone Injection Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Edaravone Injection Sales by Application (2017-2022) & (K MT)

Table 64. Middle East & Africa Edaravone Injection Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Edaravone Injection

Table 66. Key Market Challenges & Risks of Edaravone Injection

Table 67. Key Industry Trends of Edaravone Injection

Table 68. Edaravone Injection Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Edaravone Injection Distributors List

Table 71. Edaravone Injection Customer List

Table 72. Global Edaravone Injection Sales Forecast by Region (2023-2028) & (K MT)

Table 73. Global Edaravone Injection Sales Market Forecast by Region

Table 74. Global Edaravone Injection Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Edaravone Injection Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Edaravone Injection Sales Forecast by Country (2023-2028) & (K MT)

Table 77. Americas Edaravone Injection Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Edaravone Injection Sales Forecast by Region (2023-2028) & (K MT)

Table 79. APAC Edaravone Injection Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Edaravone Injection Sales Forecast by Country (2023-2028) & (K MT)

Table 81. Europe Edaravone Injection Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Edaravone Injection Sales Forecast by Country (2023-2028) & (K MT)

Table 83. Middle East & Africa Edaravone Injection Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Edaravone Injection Sales Forecast by Type (2023-2028) & (K MT)

Table 85. Global Edaravone Injection Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Edaravone Injection Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Edaravone Injection Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Edaravone Injection Sales Forecast by Application (2023-2028) & (K MT)

Table 89. Global Edaravone Injection Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Edaravone Injection Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Edaravone Injection Revenue Market Share Forecast by Application (2023-2028)

Table 92. Mitsubishi Tanabe Pharma Basic Information, Edaravone Injection Manufacturing Base, Sales Area and Its Competitors

Table 93. Mitsubishi Tanabe Pharma Edaravone Injection Product Offered

Table 94. Mitsubishi Tanabe Pharma Edaravone Injection Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)

Table 95. Mitsubishi Tanabe Pharma Main Business

Table 96. Mitsubishi Tanabe Pharma Latest Developments

List of Figures

Figure 1. Picture of Edaravone Injection

Figure 2. Edaravone Injection Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Edaravone Injection Sales Growth Rate 2017-2028 (K MT)

Figure 7. Global Edaravone Injection Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Edaravone Injection Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of 20ml

Figure 10. Product Picture of 100ml

Figure 11. Global Edaravone Injection Sales Market Share by Type in 2021

Figure 12. Global Edaravone Injection Revenue Market Share by Type (2017-2022)

Figure 13. Edaravone Injection Consumed in Hospital

Figure 14. Global Edaravone Injection Market: Hospital (2017-2022) & (K MT)

Figure 15. Edaravone Injection Consumed in Pharmacy

Figure 16. Global Edaravone Injection Market: Pharmacy (2017-2022) & (K MT)

Figure 17. Global Edaravone Injection Sales Market Share by Application (2017-2022)

Figure 18. Global Edaravone Injection Revenue Market Share by Application in 2021

Figure 19. Edaravone Injection Revenue Market by Company in 2021 ($ Million)

Figure 20. Global Edaravone Injection Revenue Market Share by Company in 2021

Figure 21. Global Edaravone Injection Sales Market Share by Geographic Region (2017-2022)

Figure 22. Global Edaravone Injection Revenue Market Share by Geographic Region in 2021

Figure 23. Global Edaravone Injection Sales Market Share by Region (2017-2022)

Figure 24. Global Edaravone Injection Revenue Market Share by Country/Region in 2021

Figure 25. Americas Edaravone Injection Sales 2017-2022 (K MT)

Figure 26. Americas Edaravone Injection Revenue 2017-2022 ($ Millions)

Figure 27. APAC Edaravone Injection Sales 2017-2022 (K MT)

Figure 28. APAC Edaravone Injection Revenue 2017-2022 ($ Millions)

Figure 29. Europe Edaravone Injection Sales 2017-2022 (K MT)

Figure 30. Europe Edaravone Injection Revenue 2017-2022 ($ Millions)

Figure 31. Middle East & Africa Edaravone Injection Sales 2017-2022 (K MT)

Figure 32. Middle East & Africa Edaravone Injection Revenue 2017-2022 ($ Millions)

Figure 33. Americas Edaravone Injection Sales Market Share by Country in 2021

Figure 34. Americas Edaravone Injection Revenue Market Share by Country in 2021

Figure 35. United States Edaravone Injection Revenue Growth 2017-2022 ($ Millions)

Figure 36. Canada Edaravone Injection Revenue Growth 2017-2022 ($ Millions)

Figure 37. Mexico Edaravone Injection Revenue Growth 2017-2022 ($ Millions)

Figure 38. Brazil Edaravone Injection Revenue Growth 2017-2022 ($ Millions)

Figure 39. APAC Edaravone Injection Sales Market Share by Region in 2021

Figure 40. APAC Edaravone Injection Revenue Market Share by Regions in 2021

Figure 41. China Edaravone Injection Revenue Growth 2017-2022 ($ Millions)

Figure 42. Japan Edaravone Injection Revenue Growth 2017-2022 ($ Millions)

Figure 43. South Korea Edaravone Injection Revenue Growth 2017-2022 ($ Millions)

Figure 44. Southeast Asia Edaravone Injection Revenue Growth 2017-2022 ($ Millions)

Figure 45. India Edaravone Injection Revenue Growth 2017-2022 ($ Millions)

Figure 46. Australia Edaravone Injection Revenue Growth 2017-2022 ($ Millions)

Figure 47. Europe Edaravone Injection Sales Market Share by Country in 2021

Figure 48. Europe Edaravone Injection Revenue Market Share by Country in 2021

Figure 49. Germany Edaravone Injection Revenue Growth 2017-2022 ($ Millions)

Figure 50. France Edaravone Injection Revenue Growth 2017-2022 ($ Millions)

Figure 51. UK Edaravone Injection Revenue Growth 2017-2022 ($ Millions)

Figure 52. Italy Edaravone Injection Revenue Growth 2017-2022 ($ Millions)

Figure 53. Russia Edaravone Injection Revenue Growth 2017-2022 ($ Millions)

Figure 54. Middle East & Africa Edaravone Injection Sales Market Share by Country in 2021

Figure 55. Middle East & Africa Edaravone Injection Revenue Market Share by Country in 2021

Figure 56. Egypt Edaravone Injection Revenue Growth 2017-2022 ($ Millions)

Figure 57. South Africa Edaravone Injection Revenue Growth 2017-2022 ($ Millions)

Figure 58. Israel Edaravone Injection Revenue Growth 2017-2022 ($ Millions)

Figure 59. Turkey Edaravone Injection Revenue Growth 2017-2022 ($ Millions)

Figure 60. GCC Country Edaravone Injection Revenue Growth 2017-2022 ($ Millions)

Figure 61. Manufacturing Cost Structure Analysis of Edaravone Injection in 2021

Figure 62. Manufacturing Process Analysis of Edaravone Injection

Figure 63. Industry Chain Structure of Edaravone Injection

Figure 64. Channels of Distribution

Figure 65. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390